anti-endotheliase antibodies (Dendreon/Dyax)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-endotheliase antibodies (Dendreon/Dyax)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego LlcDyax Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A